Statement of Organization, Functions, and Delegations of Authority, 57189-57190 [2015-24006]

Download as PDF Federal Register / Vol. 80, No. 183 / Tuesday, September 22, 2015 / Notices hour, which includes time to review the interview protocol with the interviewer, respond to the interview questions, and review a summary report about the Champion’s practices. The summary will be written as a success story and will be posted on the CDC Web site. Additional Information Information received from nominees will be stored in a password protected file on a secure server. The challenge Web site may post the number of nominations received but will not include information about individual nominees. The database of information submitted by nominees will not be posted on the Web site. Personal information collected and stored from nominees will only include general details, such as the organization name, address, and contact information of the nominee. This type of information is generally publically available. The nomination form and submission will collect and store only aggregate clinical data through the nomination process; no individual identifiable patient data will be collected or stored. Confidential or propriety data, clearly marked as such, will be secured to the full extent allowable by law. Information for selected Champions, such as the hospital or health system’s name, location, VTE prevention outcomes, and practices that support HA–VTE prevention will be shared through press releases, the challenge Web site, social media, and other HHS/ CDC resources. Summary data on the types of systems and processes used to increase VTE prevention will be shared in documents or other communication products that describe generally used practices for successful VTE prevention. HHS/CDC will use the summary data only as described. tkelley on DSK3SPTVN1PROD with NOTICES Compliance With Rules and Contacting Contest Winners Finalists must comply with all terms and conditions of these official rules, and winning is contingent upon fulfilling all requirements herein. The finalists will be notified by email, telephone, or mail after the date of judging. Privacy Personal information provided by entrants on the nomination form through the challenge Web site will be used to contact selected finalists. Information is not collected for commercial marketing. Winners are permitted to cite that they won this challenge. The names, cities, and states of selected Champions will be made VerDate Sep<11>2014 17:39 Sep 21, 2015 Jkt 235001 available in HHS/CDC’s educational materials on VTE prevention and at recognition events. General Conditions HHS/CDC reserves the right to cancel suspend, and/or modify the challenge, or any part of it, for any reason, as HHS/ CDC’s sole discretion. Dated: September 15, 2015. Sandra Cashman, Acting Director, Division of the Executive Secretariat, Office of the Chief of Staff, Centers for Disease Control and Prevention. [FR Doc. 2015–23990 Filed 9–21–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772–76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 80 FR 34643–34644, dated June 6, 2015) is amended to reflect the reorganization of the National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. Section C–B, Organization and Functions, is hereby amended as follows: Delete in its entirety the title and function statements for the Division of Respiratory Disease Studies (CCH) and insert the following: Respiratory Health Division (CCH). The Respiratory Health Division (RHD) seeks to advance protection against work-related hazards and exposures that cause or contribute to respiratory illness, injury, and death and to promote workplace-based interventions that improve respiratory health. To accomplish its mission, the Division gathers and synthesizes information, makes recommendations, and delivers products and services to a range of stakeholders, including partners able to effect prevention. Specifically, RHD: (1) Prevents work-related respiratory disease and improves workers’ respiratory health by generating new knowledge and transferring that knowledge into practice; (2) plans, designs, and conducts a national research program relevant to preventing PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 57189 occupational respiratory disease and optimizing workers’ respiratory health; (3) upon request, conducts hazard evaluations and provides technical assistance to address challenges, including emerging issues, in occupational respiratory disease; (4) plans, designs, and conducts a national surveillance program for occupational and work-related respiratory disease; (5) communicates study findings to prevent occupational respiratory disease and optimize workers’ respiratory health, and evaluates the effectiveness of these communications; (6) administers a program of legislatively mandated medical monitoring services for coal miners under the Federal Mine Safety and Health Act of 1977; and (7) provides rewarding educational and training opportunities in occupational and workrelated respiratory disease prevention to visiting scientists, Epidemiologic Investigations Service Officers, fellows, residents, interns, students and others through a variety of temporary assignments in various Division activities. Office of the Director (CCH1). Directs and manages the operations of the Respiratory Health Division. Field Studies Branch (CCHB). (1) Plans, designs, and conducts short- and long-term field investigations relevant to preventing occupational respiratory diseases and optimizing workers’ respiratory health; (2) responds to requests for health hazard evaluations and technical assistance relevant to occupational respiratory disease; (3) conducts morbidity and mortality studies relating to occupational respiratory diseases in selected worker populations and the general population in order to identify causal agents and other risk factors, quantify exposure effect relationships, and evaluate prevalence and severity of specific respiratory diseases; (4) conducts environmental studies, medical test evaluations, industrial hygiene research, laboratory research, demonstrations of workplace exposures and controls, and studies the challenges created by new technologies; (5) provides statistical design and implements data analysis and verification for Division research projects; and (6) develops and evaluates research methods of data collection, processing, and statistical analysis that are relevant to the Division mission, including medical tests, sampling approaches and equipment, sample analyses, exposure and dose assessment and modeling (including dermal exposure), bioavailability of exposures, biomarkers of exposure and health effects, and protective measures. E:\FR\FM\22SEN1.SGM 22SEN1 tkelley on DSK3SPTVN1PROD with NOTICES 57190 Federal Register / Vol. 80, No. 183 / Tuesday, September 22, 2015 / Notices Surveillance Branch (CCHD). (1) Collects, analyzes, and disseminates accurate and timely health and hazard information related to occupational respiratory diseases and workers’ respiratory health, and collaborates in the establishment and analysis of health surveillance systems at the national and state level in order to: (a) provide information relating to overall incidence, prevalence, mortality, and impact of occupational respiratory diseases and workers’ respiratory health; (b) describe the occurrence of specific diseases with regard to occupation, industry, exposures, geography, demographic characteristics, temporal trends, and other relevant factors for which information is available; (c) describe the distribution and trends in occupational exposure to agents responsible for respiratory diseases; (d) identify emerging risks for respiratory disease; (e) assess racial/ ethnic and other disparities in the occurrence of occupational respiratory diseases and occupational exposures to agents responsible for respiratory diseases; and (f) evaluate impact of interventions, policies, and program activities on the occurrence of occupational respiratory disease; (2) synthesizes data to frame recommendations for priority setting, hypothesis generation, and improved methods for data collection; (3) disseminates information through development and publication of timely information and reports describing workplace hazards and exposures and work-related occupational lung diseases, and application of communication science, media principles, and web design to enhance access to and use of data and information; (4) develops and evaluates innovative surveillance methods; (5) coordinates with other Federal agencies, promulgates rules, and implements programs as authorized by the Federal Mine Safety and Health Act of 1977 and its subsequent amendments, to provide for the collection and reporting of health and hazard surveillance data related to occupational respiratory diseases in coal miners, including planning, coordinating, and processing the medical examinations provided for miners, operating an approval program for participating medical facilities and physicians, and evaluating and approving employer programs for the examination of miners in accordance with published regulations; (6) provides technical assistance and recommendations concerning medical VerDate Sep<11>2014 17:39 Sep 21, 2015 Jkt 235001 screening and health surveillance of workers exposed to respiratory hazards in the workplace, including administering a national program of spirometry training, providing training and testing on the classification of radiographs for the pneumoconioses, and collaborating with national (e.g., American College of Radiology, American Thoracic Society) and international (e.g., International Labour Organization) groups to develop and improve occupational respiratory disease medical surveillance methods; and (7) establishes collaborations to identify, support, and evaluate interventions designed to improve respiratory health in the workplace. James Seligman, Acting Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2015–24006 Filed 9–21–15; 8:45 am] BILLING CODE 4160–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30 Day–15–15AOX] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Written comments and/or suggestions regarding the items contained in this notice should be directed to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project Harmful Algal Bloom Illness Surveillance System (HABISS)—NEW— National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC). Background and Brief Description The National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) is requesting approval for surveillance activities through Harmful Algal Bloomrelated Illness Surveillance System (HABISS). HABISS data surveillance was previously covered under OMB Control No. 0920–0004. Previous Harmful Algal Bloom (HAB) surveillance under HABISS ceased due to defunding. NCEZID is now managing the HAB surveillance module. Surveillance through HABISS is now a priority within NCEZID due to the Great Lakes Restorative Initiative. The goal of the Harmful Algal Bloomrelated Illness Surveillance System (HABISS) is to receive data on harmful algal blooms (HABs) and human and animal illnesses related to HAB exposures. Data reported to HABISS will be accessible to state health departments, federal partners and other stakeholders to better characterize HABs and single human and animal illness related to HAB exposures and to inform future prevention efforts. Data will be collected electronically, with data elements collected via the National Outbreak Reporting System (NORS). Single human and animal illnesses related to HAB exposures, and environmental data about HABs will be voluntarily reported by state agencies. The data collected will be analyzed and presented through summaries and reports. The total burden is 57 hours. E:\FR\FM\22SEN1.SGM 22SEN1

Agencies

[Federal Register Volume 80, Number 183 (Tuesday, September 22, 2015)]
[Notices]
[Pages 57189-57190]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-24006]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Statement of Organization, Functions, and Delegations of 
Authority

    Part C (Centers for Disease Control and Prevention) of the 
Statement of Organization, Functions, and Delegations of Authority of 
the Department of Health and Human Services (45 FR 67772-76, dated 
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as 
amended most recently at 80 FR 34643-34644, dated June 6, 2015) is 
amended to reflect the reorganization of the National Institute for 
Occupational Safety and Health, Centers for Disease Control and 
Prevention.
    Section C-B, Organization and Functions, is hereby amended as 
follows:
    Delete in its entirety the title and function statements for the 
Division of Respiratory Disease Studies (CCH) and insert the following:
    Respiratory Health Division (CCH). The Respiratory Health Division 
(RHD) seeks to advance protection against work-related hazards and 
exposures that cause or contribute to respiratory illness, injury, and 
death and to promote workplace-based interventions that improve 
respiratory health. To accomplish its mission, the Division gathers and 
synthesizes information, makes recommendations, and delivers products 
and services to a range of stakeholders, including partners able to 
effect prevention. Specifically, RHD: (1) Prevents work-related 
respiratory disease and improves workers' respiratory health by 
generating new knowledge and transferring that knowledge into practice; 
(2) plans, designs, and conducts a national research program relevant 
to preventing occupational respiratory disease and optimizing workers' 
respiratory health; (3) upon request, conducts hazard evaluations and 
provides technical assistance to address challenges, including emerging 
issues, in occupational respiratory disease; (4) plans, designs, and 
conducts a national surveillance program for occupational and work-
related respiratory disease; (5) communicates study findings to prevent 
occupational respiratory disease and optimize workers' respiratory 
health, and evaluates the effectiveness of these communications; (6) 
administers a program of legislatively mandated medical monitoring 
services for coal miners under the Federal Mine Safety and Health Act 
of 1977; and (7) provides rewarding educational and training 
opportunities in occupational and work-related respiratory disease 
prevention to visiting scientists, Epidemiologic Investigations Service 
Officers, fellows, residents, interns, students and others through a 
variety of temporary assignments in various Division activities.
    Office of the Director (CCH1). Directs and manages the operations 
of the Respiratory Health Division.
    Field Studies Branch (CCHB). (1) Plans, designs, and conducts 
short- and long-term field investigations relevant to preventing 
occupational respiratory diseases and optimizing workers' respiratory 
health; (2) responds to requests for health hazard evaluations and 
technical assistance relevant to occupational respiratory disease; (3) 
conducts morbidity and mortality studies relating to occupational 
respiratory diseases in selected worker populations and the general 
population in order to identify causal agents and other risk factors, 
quantify exposure effect relationships, and evaluate prevalence and 
severity of specific respiratory diseases; (4) conducts environmental 
studies, medical test evaluations, industrial hygiene research, 
laboratory research, demonstrations of workplace exposures and 
controls, and studies the challenges created by new technologies; (5) 
provides statistical design and implements data analysis and 
verification for Division research projects; and (6) develops and 
evaluates research methods of data collection, processing, and 
statistical analysis that are relevant to the Division mission, 
including medical tests, sampling approaches and equipment, sample 
analyses, exposure and dose assessment and modeling (including dermal 
exposure), bioavailability of exposures, biomarkers of exposure and 
health effects, and protective measures.

[[Page 57190]]

    Surveillance Branch (CCHD). (1) Collects, analyzes, and 
disseminates accurate and timely health and hazard information related 
to occupational respiratory diseases and workers' respiratory health, 
and collaborates in the establishment and analysis of health 
surveillance systems at the national and state level in order to: (a) 
provide information relating to overall incidence, prevalence, 
mortality, and impact of occupational respiratory diseases and workers' 
respiratory health; (b) describe the occurrence of specific diseases 
with regard to occupation, industry, exposures, geography, demographic 
characteristics, temporal trends, and other relevant factors for which 
information is available; (c) describe the distribution and trends in 
occupational exposure to agents responsible for respiratory diseases; 
(d) identify emerging risks for respiratory disease; (e) assess racial/
ethnic and other disparities in the occurrence of occupational 
respiratory diseases and occupational exposures to agents responsible 
for respiratory diseases; and (f) evaluate impact of interventions, 
policies, and program activities on the occurrence of occupational 
respiratory disease; (2) synthesizes data to frame recommendations for 
priority setting, hypothesis generation, and improved methods for data 
collection; (3) disseminates information through development and 
publication of timely information and reports describing workplace 
hazards and exposures and work-related occupational lung diseases, and 
application of communication science, media principles, and web design 
to enhance access to and use of data and information; (4) develops and 
evaluates innovative surveillance methods; (5) coordinates with other 
Federal agencies, promulgates rules, and implements programs as 
authorized by the Federal Mine Safety and Health Act of 1977 and its 
subsequent amendments, to provide for the collection and reporting of 
health and hazard surveillance data related to occupational respiratory 
diseases in coal miners, including planning, coordinating, and 
processing the medical examinations provided for miners, operating an 
approval program for participating medical facilities and physicians, 
and evaluating and approving employer programs for the examination of 
miners in accordance with published regulations; (6) provides technical 
assistance and recommendations concerning medical screening and health 
surveillance of workers exposed to respiratory hazards in the 
workplace, including administering a national program of spirometry 
training, providing training and testing on the classification of 
radiographs for the pneumoconioses, and collaborating with national 
(e.g., American College of Radiology, American Thoracic Society) and 
international (e.g., International Labour Organization) groups to 
develop and improve occupational respiratory disease medical 
surveillance methods; and (7) establishes collaborations to identify, 
support, and evaluate interventions designed to improve respiratory 
health in the workplace.

James Seligman,
Acting Chief Operating Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2015-24006 Filed 9-21-15; 8:45 am]
BILLING CODE 4160-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.